Terms: = Germ cell tumor AND GATA2, NFE1B, 2624, ENSG00000179348, MGC2306, P23769 AND Treatment
8 results:
1. Lineage specific transcription factor waves reprogram neuroblastoma from self-renewal to differentiation.
Banerjee D; Bagchi S; Liu Z; Chou HC; Xu M; Sun M; Aloisi S; Vaksman Z; Diskin SJ; Zimmerman M; Khan J; Gryder B; Thiele CJ
Nat Commun; 2024 Apr; 15(1):3432. PubMed ID: 38653778
[TBL] [Abstract] [Full Text] [Related]
2. Overview of the 2022 WHO Classification of Pituitary Adenomas/Pituitary Neuroendocrine tumors: Clinical Practices, Controversies, and Perspectives.
Wan XY; Chen J; Wang JW; Liu YC; Shu K; Lei T
Curr Med Sci; 2022 Dec; 42(6):1111-1118. PubMed ID: 36544040
[TBL] [Abstract] [Full Text] [Related]
3. PATZ1 fusions define a novel molecularly distinct neuroepithelial tumor entity with a broad histological spectrum.
Alhalabi KT; Stichel D; Sievers P; Peterziel H; Sommerkamp AC; Sturm D; Wittmann A; Sill M; Jäger N; Beck P; Pajtler KW; Snuderl M; Jour G; Delorenzo M; Martin AM; Levy A; Dalvi N; Hansford JR; Gottardo NG; Uro-Coste E; Maurage CA; Godfraind C; Vandenbos F; Pietsch T; Kramm C; Filippidou M; Kattamis A; Jones C; Øra I; Mikkelsen TS; Zapotocky M; Sumerauer D; Scheie D; McCabe M; Wesseling P; Tops BBJ; Kranendonk MEG; Karajannis MA; Bouvier N; Papaemmanuil E; Dohmen H; Acker T; von Hoff K; Schmid S; Miele E; Filipski K; Kitanovski L; Krskova L; Gojo J; Haberler C; Alvaro F; Ecker J; Selt F; Milde T; Witt O; Oehme I; Kool M; von Deimling A; Korshunov A; Pfister SM; Sahm F; Jones DTW
Acta Neuropathol; 2021 Nov; 142(5):841-857. PubMed ID: 34417833
[TBL] [Abstract] [Full Text] [Related]
4. IDH1-mutated transgenic zebrafish lines: An in-vivo model for drug screening and functional analysis.
Gao Y; de Wit M; Struys EA; van der Linde HCZ; Salomons GS; Lamfers MLM; Willemsen R; Sillevis Smitt PAE; French PJ
PLoS One; 2018; 13(6):e0199737. PubMed ID: 29953513
[TBL] [Abstract] [Full Text] [Related]
5. Patients with melanoma treated with an anti-PD-1 antibody beyond RECIST progression: a US Food and Drug Administration pooled analysis.
Beaver JA; Hazarika M; Mulkey F; Mushti S; Chen H; He K; Sridhara R; Goldberg KB; Chuk MK; Chi DC; Chang J; Barone A; Balasubramaniam S; Blumenthal GM; Keegan P; Pazdur R; Theoret MR
Lancet Oncol; 2018 Feb; 19(2):229-239. PubMed ID: 29361469
[TBL] [Abstract] [Full Text] [Related]
6. Role of down-regulated neutral ceramidase during all-trans retinoic acid-induced neuronal differentiation in SH-SY5Y neuroblastoma cells.
Tanaka K; Tamiya-Koizumi K; Hagiwara K; Ito H; Takagi A; Kojima T; Suzuki M; Iwaki S; Fujii S; Nakamura M; Banno Y; Kannagi R; Tsurumi T; Kyogashima M; Murate T
J Biochem; 2012 Jun; 151(6):611-20. PubMed ID: 22451680
[TBL] [Abstract] [Full Text] [Related]
7. Cholinergic switch associated with morphological differentiation in neuroblastoma.
Bourdeaut F; Janoueix-Lerosey I; Lucchesi C; Paris R; Ribeiro A; de Pontual L; Amiel J; Lyonnet S; Pierron G; Michon J; Peuchmaur M; Delattre O
J Pathol; 2009 Dec; 219(4):463-72. PubMed ID: 19768740
[TBL] [Abstract] [Full Text] [Related]
8. Rapid turnover of GATA-2 via ubiquitin-proteasome protein degradation pathway.
Minegishi N; Suzuki N; Kawatani Y; Shimizu R; Yamamoto M
Genes Cells; 2005 Jul; 10(7):693-704. PubMed ID: 15966900
[TBL] [Abstract] [Full Text] [Related]
